Breast Biopsy Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Breast Biopsy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 16.0% during the forecast period.
This report presents the market size and development trends by detailing the Breast Biopsy market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Breast Biopsy market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Breast Biopsy industry and will help you to build a panoramic view of the industrial development.
Breast Biopsy Market, By Type:
Vacuum Assisted Biopsy (VAB)
Core Needle Biopsy (CNB)
Fine Needle Aspiration Biopsy (FNAB)
Breast Biopsy Market, By Application:
Diagnostic Centers
Hospitals
Some of the leading players are as follows:
Hologic Inc.
F. Hoffmann-La Roche Ltd.
Ethicon Endo Surgery (Johnson & Johnson)
Argon Medical Devices
Galini SRL
Carestream Health
Leica Biosystems Nussloch GmbH
Cardinal Health
Scion Medical Technologies
Laboratory Corporation of America Holdings
C. R. Bard, Inc.
Zenalux Biomedical, Inc.
Encapsule medical Devices LLC.
Aurora Imaging Technology Inc.
Intact Medical Corporation
Becton and Dickinson Company
OncoCyte Corporation
PerkinElmer
Cook Medical Incorporated
Planmed Oy
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Breast Biopsy Market: Technology Type Analysis
-
4.1 Breast Biopsy Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Breast Biopsy Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Vacuum Assisted Biopsy (VAB)
4.3.2 Core Needle Biopsy (CNB)
4.3.3 Fine Needle Aspiration Biopsy (FNAB)
5 Breast Biopsy Market: Product Analysis
-
5.1 Breast Biopsy Product Market Share Analysis, 2018 & 2026
-
5.2 Breast Biopsy Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Breast Biopsy Market: Application Analysis
-
6.1 Breast Biopsy Application Market Share Analysis, 2018 & 2026
-
6.2 Breast Biopsy Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Diagnostic Centers
6.3.2 Hospitals
7 Breast Biopsy Market: Regional Analysis
-
7.1 Breast Biopsy Regional Market Share Analysis, 2018 & 2026
-
7.2 Breast Biopsy Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Hologic Inc.
9.1.1 Hologic Inc. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 F. Hoffmann-La Roche Ltd. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Ethicon Endo Surgery (Johnson & Johnson)
9.3.1 Ethicon Endo Surgery (Johnson & Johnson) Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Argon Medical Devices
9.4.1 Argon Medical Devices Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Galini SRL
9.5.1 Galini SRL Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Carestream Health
9.6.1 Carestream Health Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Leica Biosystems Nussloch GmbH
9.7.1 Leica Biosystems Nussloch GmbH Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Cardinal Health
9.8.1 Cardinal Health Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Scion Medical Technologies
9.9.1 Scion Medical Technologies Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Laboratory Corporation of America Holdings
9.10.1 Laboratory Corporation of America Holdings Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 C. R. Bard, Inc.
9.11.1 C. R. Bard, Inc. Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Zenalux Biomedical, Inc.
9.12.1 Zenalux Biomedical, Inc. Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Encapsule medical Devices LLC.
9.13.1 Encapsule medical Devices LLC. Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Aurora Imaging Technology Inc.
9.14.1 Aurora Imaging Technology Inc. Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Intact Medical Corporation
9.15.1 Intact Medical Corporation Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Becton and Dickinson Company
9.16.1 Becton and Dickinson Company Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 OncoCyte Corporation
9.17.1 OncoCyte Corporation Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 PerkinElmer
9.18.1 PerkinElmer Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
9.19 Cook Medical Incorporated
9.19.1 Cook Medical Incorporated Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis
9.20 Planmed Oy
9.20.1 Planmed Oy Company overview
9.20.2 Financial performance
9.20.3 Product benchmarking
9.20.4 Strategic initiatives
9.20.5 SWOT analysis
The List of Tables and Figures (Totals 86 Figures and 130 Tables)
Figure Vacuum Assisted Biopsy (VAB) Breast Biopsy market, 2015 - 2026 (USD Million)
Figure Core Needle Biopsy (CNB) Breast Biopsy market, 2015 - 2026 (USD Million)
Figure Fine Needle Aspiration Biopsy (FNAB) Breast Biopsy market, 2015 - 2026 (USD Million)
Figure Diagnostic Centers market, 2015 - 2026 (USD Million)
Figure Hospitals market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Breast Biopsy market, by country, 2015 - 2026 (USD Million)
-
Table North America Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table North America Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table North America Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Canada Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Canada Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Europe Breast Biopsy market, by country, 2015 - 2026 (USD Million)
-
Table Europe Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Europe Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Europe Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Germany Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Germany Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table France Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table France Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Italy Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Italy Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Spain Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Spain Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Breast Biopsy market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table China Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table China Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Japan Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Japan Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table India Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table India Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Breast Biopsy market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table MEA Breast Biopsy market, by country, 2015 - 2026 (USD Million)
-
Table MEA Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table MEA Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table MEA Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Breast Biopsy market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Breast Biopsy market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Breast Biopsy market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Hologic Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table F. Hoffmann-La Roche Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ethicon Endo Surgery (Johnson & Johnson) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Argon Medical Devices Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Galini SRL Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Carestream Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Leica Biosystems Nussloch GmbH Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cardinal Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Scion Medical Technologies Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Laboratory Corporation of America Holdings Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table C. R. Bard, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Zenalux Biomedical, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Encapsule medical Devices LLC. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aurora Imaging Technology Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Intact Medical Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Becton and Dickinson Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table OncoCyte Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PerkinElmer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cook Medical Incorporated Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Planmed Oy Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis